Valuation: DexCom, Inc.

Market Cap 32.62B 28.26B 26.72B 24.19B 45.4B 3,129B 45.74B 319B 123B 1,587B 123B 120B 5,060B P/E 2026 *
34.7x
P/E 2027 * 29.1x
Enterprise Value 31.86B 27.6B 26.1B 23.63B 44.34B 3,056B 44.68B 311B 120B 1,550B 120B 117B 4,942B EV / Sales 2026 *
6.09x
EV / Sales 2027 * 5.44x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 week+3.15%
Current month-4.10%
1 month-3.33%
3 months+16.82%
6 months+33.14%
Current year+31.16%
1 week 70.91
Extreme 70.91
75.59
1 month 70.91
Extreme 70.91
79.28
3 years 46.85
Extreme 46.85
132
5 years 46.85
Extreme 46.85
144.8
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+2.46%-2.14%+16.48%-16.67% 31.95B
-1.03%-3.31%-22.31%+0.29% 178B
-0.05%+1.47%+0.34%+14.65% 120B
-0.90%-0.43%+10.94%+81.33% 62.25B
+1.65%+3.81%+0.10%-29.51% 49.82B
-0.07%-3.83%+3.02%+38.68% 48.54B
+2.09%+2.27%+14.38%-10.28% 31.95B
-1.47%-7.44% - - 28.59B
+2.76%+8.07%+41.73%-7.40% 25B
+0.47%-0.64%-10.59%+4.21% 21.59B
Average +0.39%-1.21%+6.01%+8.37% 62.9B
Weighted average by Cap. -0.11%-1.28%-2.29%+11.10%

Financials

2026 *2027 *
Net sales 5.23B 4.53B 4.28B 3.88B 7.28B 502B 7.33B 51.12B 19.67B 254B 19.65B 19.21B 811B 5.8B 5.02B 4.75B 4.3B 8.07B 556B 8.13B 56.69B 21.81B 282B 21.79B 21.3B 900B
Net income 974M 844M 798M 723M 1.36B 93.46B 1.37B 9.52B 3.66B 47.39B 3.66B 3.58B 151B 1.15B 995M 941M 852M 1.6B 110B 1.61B 11.23B 4.32B 55.88B 4.32B 4.22B 178B
Net Debt -761M -659M -623M -564M -1.06B -73.01B -1.07B -7.44B -2.86B -37.02B -2.86B -2.8B -118B -1.06B -919M -869M -787M -1.48B -102B -1.49B -10.38B -3.99B -51.63B -3.99B -3.9B -165B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
15/09/26 €75.00 +2.46%
14/09/26 €73.20 +1.94%
11/09/26 €71.81 -1.10%
10/09/26 €72.61 +0.72%
09/09/26 €72.09 -0.85%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.45USD
Average target price
94.12USD
Spread / Average Target
+8.87%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!